Literature DB >> 16080546

Severity and duration of chronic dysphagia following treatment for head and neck cancer.

Nam P Nguyen1, Candace C Moltz, Cheryl Frank, Ulf Karlsson, Herbert J Smith, Phuc D Nguyen, Paul Vos, Ly M Nguyen, Sue Rose, Suresh Dutta, Sabah Sallah.   

Abstract

UNLABELLED: The purpose of this investigation was to evaluate chronic dysphagia (lasting 3 or more months) following treatment for head and neck cancer. Since dysphagia is a common sequela post therapy in cancer survivors, it may be helpful for the clinician to be aware of the persistence of dysphagia as well as its usual severity. Modified Barium Swallow (MBS) examinations were performed in cancer-free patients who complained of dysphagia following treatment for head and neck cancer. The severity of the dysphagia was graded on a scale of 1 to 7. Each patient had sequential MBS and underwent swallowing therapy in between. The severity of dysphagia was compared between the first and last MBS study to determine whether the swallowing function had returned to normal.
RESULTS: Between 1996 and 2004, 12 patients with dysphagia underwent repeated MBS following treatment. Swallowing function did not return to normal in all patients. At a median time of 29 months following treatment (range 8 to 94 months), the severity of dysphagia decreased in 8 patients (67%), remained unchanged in 3 patients (25%) and worsened in 1 patient (8%). Chronic dysphagia following treatment is unlikely to resolve with time despite rehabilitation therapy. Excessive scarring following treatment may be responsible for the persistence and severity of dysphagia. Physicians should be aware of the long-term effects of dysphagia on patient nutrition and psychological well-being.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080546

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Association between severity of dysphagia and survival in patients with head and neck cancer.

Authors:  Samantha E Shune; Lucy Hynds Karnell; Michael P Karnell; Douglas J Van Daele; Gerry F Funk
Journal:  Head Neck       Date:  2011-08-30       Impact factor: 3.147

2.  Head and Neck Virtual Coach: A Randomized Control Trial of Mobile Health as an Adjunct to Swallowing Therapy During Head and Neck Radiation.

Authors:  Heather M Starmer; David Klein; Aisha Montgomery; Tessa Goldsmith; Liane McCarroll; Jeremy Richmon; F Christopher Holsinger; Beth Beadle; Praduman Jain
Journal:  Dysphagia       Date:  2022-08-12       Impact factor: 2.733

3.  Respiratory-swallow training in patients with head and neck cancer.

Authors:  Bonnie Martin-Harris; David McFarland; Elizabeth G Hill; Charlton B Strange; Kendrea L Focht; Zhuang Wan; Julie Blair; Katlyn McGrattan
Journal:  Arch Phys Med Rehabil       Date:  2014-12-11       Impact factor: 3.966

4.  The natural history of weight and swallowing outcomes in oropharyngeal cancer patients following radiation or concurrent chemoradiation therapy.

Authors:  Nedeljko Jovanovic; Colleen Dreyer; Sarah Hawkins; Kendra Thouless; David Palma; Philip C Doyle; Julie A Theurer
Journal:  Support Care Cancer       Date:  2020-08-01       Impact factor: 3.603

5.  Successful closure of pharyngo-cutaneous and phayryngo-tracheal fistulas using removable hypopharyngeal stent after laryngectomy for laryngeal carcinoma.

Authors:  Mohamad A Eloubeidi; Desiree E Morgan; William R Carroll; Lawrence F Johnson
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

6.  Development and evaluation of screening dysphagia tools for observational studies and routine care in cancer patients.

Authors:  Michael Borean; Kishan Shani; M Catherine Brown; Judy Chen; Mindy Liang; Joel Karkada; Simranjit Kooner; Mark K Doherty; Grainne M O'Kane; Raymond Jang; Elena Elimova; Rebecca K Wong; Gail E Darling; Wei Xu; Doris Howell; Geoffrey Liu
Journal:  Health Sci Rep       Date:  2018-05-21

Review 7.  Dysphagia in Head and Neck Cancer Patients: Pretreatment Evaluation, Predictive Factors, and Assessment during Radio-Chemotherapy, Recommendations.

Authors:  Nerina Denaro; Marco C Merlano; Elvio G Russi
Journal:  Clin Exp Otorhinolaryngol       Date:  2013-09-04       Impact factor: 3.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.